Documentation centre

Gaba P, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Tardif JC, Giugliano RP, Martens FMAC, Gibson CM, Ballantyne CM, REDUCE-IT Investigators

Cardiovascular Disease Clinical Trials Lipids/Lipoproteins

Key Publications August 29, 2022

Beyond 10-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease.

Circulation. 2022;145:1312-1323

Kohli-Lynch CN, Lewsey J, Boyd KA, French DD, Jordan N, Moran AE, Sattar N, Preiss D, Briggs AH

Cardiovascular Disease Lipids/Lipoproteins Prevention

Key Publications August 24, 2022

Reducing cardiovascular risk in the Medicare Million Hearts Risk Reduction Model: insights from the National Cardiovascular Data Registry PINNACLE registry.

Circ Cardiovasc Qual Outcomes. 2022;15:e007908

Borden WB, Wang J, Jones P, Tang Y, Contreras J, Daugherty SL, Desai NR, Virani SS, Wasfy JH, Maddox TM

Cardiovascular Disease Lipids/Lipoproteins Smoking

Key Publications August 15, 2022

The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions.

Eur J Clin Invest. 2022;52:e13693

Tirandi A, Carbone F, Montecucco F, Liberale L

Cardiovascular Disease Lipids/Lipoproteins Metabolic Syndrome

Key Publications August 4, 2022

Effects of a low-carbohydrate diet on insulin-resistant dyslipoproteinemia-a randomized controlled feeding trial.

Am J Clin Nutr. 2022;115:154-162

Ebbeling CB, Knapp A, Johnson A, Wong JMW, Greco KF, Ma C, Mora S, Ludwig DS

Clinical Trials Lipids/Lipoproteins Nutrition

Key Publications August 2, 2022

The triglyceride-glucose index as an adiposity marker and a predictor of fat loss induced by a low-calorie diet.

Eur J Clin Invest. 2022;52:e13674

Vidal-Ostos F, Ramos-Lopez O, Blaak EE, Astrup A, Martinez JA

Lipids/Lipoproteins Nutrition Weight Loss

Key Publications July 26, 2022

Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future.

Atherosclerosis. 2022;340:51-52

Catapano AL, Ray KK, Tokgözoglu L

Cardiovascular Disease Lipids/Lipoproteins Prevention

Key Publications July 21, 2022

Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: A scientific statement from the American Heart Association.

Arterioscler Thromb Vasc Biol. 2022;42:e48-e60

Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, Lloyd-Jones DM, Marcovina SM et al.

Cardiovascular Disease Genetics Lipids/Lipoproteins

Lipoprotein (a) and diabetes mellitus.

Atherosclerosis. 2022;349:63-71

Non-genetic influences on lipoprotein(a) concentrations.

Atherosclerosis. 2022;349:53-62

Importance of carbohydrate quality: what does it mean and how to measure it?

J Nutr. 2022;152:1200-1206

Optimizing dyslipidemic cardiovascular residual risk reduction with icosapent ethyl in post-mi patients.

J Am Coll Cardiol. 2022;79:1672-1674

Prevention of cardiovascular events and mortality with icosapent ethyl in patients with prior myocardial infarction.

J Am Coll Cardiol. 2022;79:1660-1671